drugset / Trial / NCT01778244
Metformin for Treatment of Antipsychotic-induced Dyslipidemia
RandomizedFactorialQuadruple-blindTreatment
Summary
Almost all antipsychotics can induce dyslipidemia, but no treatment has been established. Metformin can improve lipid levels in obese patients. The investigators conducted a randomized, placebo-controlled study to test the efficacy of metformin for antipsychotic-induced dyslipidemia.
Timeline
- Start
- 2008-11
- Primary completion
- 2011-12
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 1000 mg | — |